Skip to main content
. 2021 Jan 9;105:525–531. doi: 10.1016/j.ijid.2021.01.009

Figure 1.

Figure 1

Flow diagram of the study population. A total of 664 patients with COVID-19 were initially analyzed. Finally, 639 non-severe patients with COVID-19 were enrolled. Among these patients, 45 received IVIG therapy and 594 received control therapy.